<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2021.762564</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Glycinergic Signaling in Macrophages and Its Application in Macrophage-Associated Diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gan</surname>
<given-names>Zhending</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1368372"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Meiyu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Donghui</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Xiaoyan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1216019"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hong</surname>
<given-names>Changming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1426933"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Jian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1052325"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Lijuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/942183"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Shengyi</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/565646"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Han</surname>
<given-names>Sufang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>College of Animal Science, South China Agricultural University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>College of Animal Science and Technology, Guangdong Polytechnic of Science and Trade</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Nanchang Academy of Agricultural Sciences</institution>, <addr-line>Nanchang</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agricultural and Rural Affairs, Lanzhou Institute of Husbandry and Pharmaceutical Science, Chinese Academy of Agricultural Science</institution>, <addr-line>Lanzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Xia Xiong, Institute of Subtropical Agriculture (CAS), China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Bi E Tan, Hunan Agricultural University, China; Xihong Zhou, Institute of Subtropical Agriculture (CAS), China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Shengyi Wang, <email xlink:href="mailto:wangshengyi@caas.cn">wangshengyi@caas.cn</email>; Sufang Han, <email xlink:href="mailto:sfhan@scau.edu.cn">sfhan@scau.edu.cn</email> </p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Nutritional Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>10</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>762564</elocation-id>
<history>
<date date-type="received">
<day>22</day>
<month>08</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>09</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Gan, Zhang, Xie, Wu, Hong, Fu, Fan, Wang and Han</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Gan, Zhang, Xie, Wu, Hong, Fu, Fan, Wang and Han</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Accumulating evidences support that amino acids direct the fate decision of immune cells. Glycine is a simple structural amino acid acting as an inhibitory neurotransmitter. Besides, glycine receptors as well as glycine transporters are found in macrophages, indicating that glycine alters the functions of macrophages besides as an inhibitory neurotransmitter. Mechanistically, glycine shapes macrophage polarization <italic>via</italic> cellular signaling pathways (e.g., NF-&#x3ba;B, NRF2, and Akt) and microRNAs. Moreover, glycine has beneficial effects in preventing and/or treating macrophage-associated diseases such as colitis, NAFLD and ischemia-reperfusion injury. Collectively, this review highlights the conceivable role of glycinergic signaling for macrophage polarization and indicates the potential application of glycine supplementation as an adjuvant therapy in macrophage-associated diseases.</p>
</abstract>
<kwd-group>
<kwd>glycine</kwd>
<kwd>macrophage</kwd>
<kwd>NF-&#x3ba;B</kwd>
<kwd>miRNA</kwd>
<kwd>inflammation</kwd>
</kwd-group>
<contract-num rid="cn001">31922079</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="114"/>
<page-count count="10"/>
<word-count count="3421"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Macrophages are found in almost all tissues such as Kupffer cells in hepatocyte (<xref ref-type="bibr" rid="B1">1</xref>) and microglia in central nervous system (<xref ref-type="bibr" rid="B2">2</xref>). These macrophages engulf cellular debris, microbes, death cells and foreign substances by stretching filopodia (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Although the polarizations of macrophages are multiple, they are roughly polarized to two distinct subsets: classically activated (M1) phenotype and alternatively activated (M2) phenotype (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Macrophages polarize into M1 phenotype to perform their pathogen-scavenging function when exposed to T-helper 1 (Th 1) type cytokines or inflammatory mediators, such as interferon gamma (IFN-&#x3b3;) and lipopolysaccharide (LPS) (<xref ref-type="bibr" rid="B7">7</xref>), or M2 phenotype to perform their anti-inflammatory effects, including wound healing and anti-tumor ability under conditions of exposure to Th 2 cytokines like IL-4 and IL-10 (<xref ref-type="bibr" rid="B8">8</xref>). Indeed, various contributors are related to the fate of macrophages. Notably, metabolism pathways and metabolites are the best examples for directing macrophage growth and survival by providing energy and substrates, and instructing functions of macrophages (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>). For example, altered amino acid metabolism [e.g., arginine metabolism (<xref ref-type="bibr" rid="B11">11</xref>)] is a well-accepted character to define macrophage polarization.</p>
<p>Traditionally, amino acids are simply divided into two categories: essential amino acids and non-essential amino acids (<xref ref-type="bibr" rid="B12">12</xref>). However, many traditionally considered non-essential amino acids are not only used as substrates for protein and peptide synthesis, but also involved in regulating metabolism, signal transduction and immune responses (<xref ref-type="bibr" rid="B13">13</xref>). Glycine consists of one carbon (C) atom, two hydrogen (H) atom, one carboxyl-group (COOH) and one amino-group (NH<sub>2</sub>) (<xref ref-type="bibr" rid="B14">14</xref>). Of note, recent studies have shown that glycine affects functions of macrophage (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>). In this review, we will summarize glycinergic system in macrophages, discuss how glycine contributes to the polarization of macrophages, and list some examples that glycine mediates macrophage-associated diseases.</p>
</sec>
<sec id="s2">
<title>Glycinergic System in Macrophages</title>
<sec id="s2_1">
<title>Glycine Receptors in Macrophages</title>
<p>Glycine is an inhibitory neurotransmitter (<xref ref-type="bibr" rid="B17">17</xref>), which exerts inhibitory effect by binding to glycine receptors (GlyRs) (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). GlyRs consist of &#x3b1; subunits (48kDa), &#x3b2; subunits (58kDa) and a 93 kDa subunit anchoring protein gephyrin (<xref ref-type="bibr" rid="B21">21</xref>). GlyRs also present in non-neuron cell membrane, such as macrophages (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B22">22</xref>). For example, the subunits of GlyRs are found in rat Kupffer cells, splenic macrophages and alveolar macrophages, and the sequences of the cloned fragment for the GlyRs &#x3b2; subunit in macrophages are more than 95% homologous with the GlyRs from the spinal cord (<xref ref-type="bibr" rid="B22">22</xref>). It should be noted that the GlyRs subunits differ in various types of macrophages. For example, Kupffer cells have &#x3b1;1-subunit, &#x3b1;4-subunit and &#x3b2;-subunit, while &#x3b1;2-subunit, &#x3b1;4-subunit and &#x3b2;-subunit are found in splenic and alveolar macrophages, as well as only &#x3b1;1 subunit in the peritoneal macrophages in rats (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). The reasons for these differences might result from the origins of macrophages (<xref ref-type="bibr" rid="B24">24</xref>) (embryonic origin and monocyte derivation), species of animals and even culture condition of isolated macrophages. It is also intriguing to know whether such difference presents in mouse or human macrophages. Although GlyRs have been identified on macrophages, no studies have investigated the effects of GlyRs subunits in macrophage fate decision. Notably, blocking the receptor with strychnine (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>) alleviates glycine-induced intracellular Ca<sup>2+</sup> decrease in LPS-stimulated macrophages (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>), suggesting the receptor highly shapes the fate decision of macrophages. To fully illustrate the function of GlyRs in macrophages, the comparative analysis towards expression and location of GlyRs in macrophages from different tissues and subsets (e.g., resting macrophages <italic>vs.</italic> M1 phenotype or M2 phenotype) should be performed. Then the function of GlyRs subunits in macrophage fate decision can be explored with chemical ablation or genetic manipulation.</p>
</sec>
<sec id="s2_2">
<title>Glycine Transporters in Macrophages</title>
<p>In the central nervous system (CNS), glycine is transported into cells by neutral-amino-acid transporters (NAATs, <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>) (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>); however, the presence of NAATs in macrophages remains to fully explore. Interestingly, rat M1 macrophages are sensitive to NAATs substrate 2-aminoisobutyric acid (AIB) (<xref ref-type="bibr" rid="B23">23</xref>) and the application of methylamino-AIB inhibits glycine-induced inward currents in microglia (<xref ref-type="bibr" rid="B31">31</xref>), suggesting that NAATs might be expressed in macrophages. As expected, it has been demonstrated that rat peritoneal macrophages express at least one of NAATs, especially glycine transporter-1 (GlyT1) (<xref ref-type="bibr" rid="B23">23</xref>). Further investigations are needed to examine the expression of NAATs in mice and human macrophages.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Neutral-amino-acid transporters which transport glycine.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">System</th>
<th valign="top" align="center">Gene</th>
<th valign="top" align="center">Transporters (Full name and abbreviation)</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" colspan="3" align="left">
<bold>Sodium dependent NAATs</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>A</bold>
</td>
<td valign="top" align="left">SLC38A1</td>
<td valign="top" align="left">Serine acetyltransferase 1 (SAT1)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">SLC38A2</td>
<td valign="top" align="left">SAT2</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">SLC38A4</td>
<td valign="top" align="left">SAT3</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Gly</bold>
</td>
<td valign="top" align="left">SLC6A9</td>
<td valign="top" align="left">Glycine transporter 1 (GlyT1)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">SLC6A5</td>
<td valign="top" align="left">GlyT2</td>
</tr>
<tr>
<td valign="top" colspan="3" align="left">
<bold>Sodium independent NAATs</bold>
</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>asc</bold>
</td>
<td valign="top" align="left">SLC7A10</td>
<td valign="top" align="left">Asc Type Amino Acid Transporter 1/2 (ASC1/2)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>imino</bold>
</td>
<td valign="top" align="left">SLC36A1</td>
<td valign="top" align="left">Proton-coupled amino acid transporter 1 (PAT1)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left">SLC36A2</td>
<td valign="top" align="left">Proton-coupled amino acid transporter 2 (PAT2)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s3">
<title>Glycine Metabolism in Macrophages</title>
<p>In mammals, glycine can be synthesized from serine, choline, threonine and hydroxyproline by different metabolic pathways (<xref ref-type="bibr" rid="B32">32</xref>). Since serine and glycine are biosynthetically linked (<xref ref-type="bibr" rid="B33">33</xref>), serine and its precursors can generate glycine. The conversion of serine to glycine catalyzed by serine hydroxymethyltransferase (SHMT) is the main way for glycine synthesis (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>). When glycine deficiency occurs, such as intrinsic glycine uptake capacity limitation or environmental glycine deprivation, SHMT can support glycine synthesis (<xref ref-type="bibr" rid="B36">36</xref>).</p>
<p>In addition to participating in protein synthesis, glycine is a precursor of peptides, nucleic acids as well as methyl donors. Upon LPS stimulation, the levels of intracellular glycine and glycine metabolites such as glutathione (GSH) and S-adenosylmethionine (SAM) increased (<xref ref-type="bibr" rid="B37">37</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>). Interestingly, adding glycine to the serine-deprived medium failed to rescue IL-1&#x3b2; secretion in macrophages upon LPS stimulation (<xref ref-type="bibr" rid="B38">38</xref>). Besides this, lack of glycine cannot affect the polarization of macrophages (<xref ref-type="bibr" rid="B39">39</xref>). Thus, extracellular glycine may not influence macrophage metabolism. U-[13C]-labeling shows that glycine is mainly converted from glucose and serine, and it can be subsequently converted to ADP, ATP, GSH and SAM (<xref ref-type="bibr" rid="B38">38</xref>). Strikingly, U-[13C]-glycine revealed a remarkable attenuation of extracellular glycine-derived GSH compared to serine (synthesis from glycine)-derived GSH (<xref ref-type="bibr" rid="B38">38</xref>). Moreover, supplementary glycine in serine deprived medium failed to rescue intracellular GSH in macrophage. These phenomena indicate that glycine utilization in macrophages is mainly through intracellular conversion of serine, not <italic>via</italic> exogenous glycine supply.</p>
</sec>
<sec id="s4">
<title>Glycine Regulates Signaling Pathways in Macrophages</title>
<p>The functions of macrophages are highly responsive to their micro-environmental stimuli. Upon the activation of Toll-like receptor (TLR) or interferon signaling, M1 macrophages arise in inflammatory to eliminate pathogens (<xref ref-type="bibr" rid="B40">40</xref>&#x2013;<xref ref-type="bibr" rid="B42">42</xref>). Whereas M2 macrophages, usually found in Th2-dominated responses, can mediate helminth immunity, asthma, and allergy (<xref ref-type="bibr" rid="B43">43</xref>).</p>
<p>Among various signaling pathways regulating macrophage inflammation, NF-&#x3ba;B is a main contributor to orchestrate macrophage polarization (<xref ref-type="bibr" rid="B44">44</xref>). Glycine can prevent the activation of nuclear factor-&#x3ba;B (NF-&#x3ba;B) by inhibiting the degradation of inhibitor of NF-&#x3ba;B (I&#x3ba;B) in pro-inflammatory macrophages (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>) (<xref ref-type="bibr" rid="B45">45</xref>). Additionally, glycine affects inflammasome assembly in pro-inflammatory macrophages (<xref ref-type="bibr" rid="B46">46</xref>). However, given glycine treatment could induce I&#x3ba;B degradation in resting macrophages (<xref ref-type="bibr" rid="B45">45</xref>), we still could not exclude the possibility that glycine causes stress responses in resting macrophages. In addition, in the context of glycine treatment, the decreased phosphorylation of I&#x3ba;B kinase-&#x3b1; (IKK-&#x3b1;) and I&#x3ba;B kinase-&#x3b2; (IKK-&#x3b2;) is also observed (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Glycine reduces LPS-induced upregulation of nucleotide binding domain like receptor protein 3 (NLRP3) (<xref ref-type="bibr" rid="B47">47</xref>). This process can be achieved by up-regulating the expression of NRF2 and its down-stream signaling pathways to eliminate reactive oxygen species (ROS) (<xref ref-type="bibr" rid="B47">47</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Probable cellular pathways that glycine influences M1 macrophages polarization. <bold>(A)</bold> Glycine inhibits the degradation of I&#x3ba;B in M1-macrophages. <bold>(B)</bold> Glycine inhibits M1-macrophages polarization <italic>via</italic> inhibiting IKK phosphorylation. <bold>(C)</bold> Glycine up-regulates NRF-2/HO-1 to blunt NLRP3 in inflammasome in M1-macrophages. <bold>(D)</bold> Glycine inhibits NF-&#x3ba;B by blocking PTEN to up-regulate Akt in M1-macrophages. LPS, lipopolysaccharide; TLR4, toll-like receptor 4; MyD88, myeloid differentiation primary response gene 88; NF-&#x3ba;B, nuclear factor kappa-light-chain-enhancer of activated B cells; I&#x3ba;B, inhibitor of NF-&#x3ba;B; IKK, I&#x3ba;B kinase; TNF-&#x3b1;, tumor necrosis alpha; TNFR, TNF-&#x3b1; receptor; TRAF, TNFR associated factor; PTEN, phosphatase and tensin homolog deleted on chromosome ten; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; Akt, protein kinase B.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-762564-g001.tif"/>
</fig>
<p>PI3K (phosphatidylinositol 3-kinase) and Akt (protein kinase B) pathways regulate tremendous signaling pathways, including NF-&#x3ba;B and mitogen-activated protein kinase (MAPK) signaling (<xref ref-type="bibr" rid="B48">48</xref>) related to macrophage polarization (<xref ref-type="bibr" rid="B49">49</xref>). Glycine can up-regulate Akt by blocking phosphatase and tensin homolog deleted on chromosome ten (PTEN), then inhibit NF-&#x3ba;B and hypoxia induced factor-1 &#x3b1; (HIF1-&#x3b1;) in microglia (<xref ref-type="bibr" rid="B50">50</xref>) in the context of ischemia-reperfusion injury. Except for macrophages, glycine also inhibits PTEN and activates Akt in other tissues or cells (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). Unfortunately, there is still no direct evidence showing whether glycine can affect proinflammatory macrophage polarization induced by canonical stimuli (e.g., LPS and/or IFN-&#x3b3;) through PTEN-Akt pathway. Notably, Akt kinases have distinct effects in macrophage polarization, with Akt1 ablation leading to an M1 phenotype and Akt2 ablation resulting in an M2 phenotype (<xref ref-type="bibr" rid="B53">53</xref>). It has not been studied which subunit of Akt is regulated by glycine. Therefore, it is necessary to further explore the connection between glycine and the Akt signaling pathway in guiding macrophages polarization.</p>
</sec>
<sec id="s5">
<title>Glycine Alters microRNAs in Macrophages</title>
<p>MicroRNAs (miRNAs) play vital roles in a great deal of biological processes (<xref ref-type="bibr" rid="B54">54</xref>) and could function as crucial regulators that support macrophage polarization (<xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>). It has been reported that some miRNAs which associated with macrophages are related with glycine. For example, glycine alleviates subarachnoid-hemorrhage (SAH) induced neuron inflammation, which is mediated by miRNA-26b/PTEN/Akt signaling pathway in microglia (<xref ref-type="bibr" rid="B56">56</xref>) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Inhibition of miRNA-26b or activation of PTEN expression suppressed the protective function of glycine (<xref ref-type="bibr" rid="B56">56</xref>). MiR-301a is abundantly expressed in hypoxic pancreatic cancer cell-derived exosomes (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>), which can promote M2 macrophage polarization through activating PTEN/PI3K signaling pathway (<xref ref-type="bibr" rid="B57">57</xref>). Interestingly, glycine has been reported to enhance the expression of miR-301a in the cortical neurons (<xref ref-type="bibr" rid="B59">59</xref>). Thus, miR-301a might be a potential target for glycine to regulate M2 macrophage functions (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Glycine shapes macrophage polarization through micro-RNAs. <bold>(A)</bold> Glycine up-regulates miR-26b to blunt M1-microglia polarization by suppressing PTEN and activating Akt. <bold>(B)</bold> Glycine possibly up-regulates miR-301a to promote M2-macrophages polarization <italic>via</italic> activating PI3K/Akt. <bold>(C, D)</bold> Glycine down-regulates miR-19a-3p. <bold>(C)</bold> MiR-19a-3p negatively control STAT1 and AMPK to blunt M1-macrophages polarization. <bold>(D)</bold> MiR-19a-3p negatively control STAT3 to inhibit M2 macrophage polarization. <bold>(E)</bold> MiR-96 and miR-137 negatively regulate GlyT1. PTEN, phosphatase and tensin homolog deleted on chromosome ten; Akt, protein kinase B; STAT, signal transducer and activator of transcription; GlyT, glycine transporter.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-12-762564-g002.tif"/>
</fig>
<p>MiR-19a-3p can suppress LPS/IFN-&#x3b3;-induced M1 macrophage polarization <italic>via</italic> inhibiting STAT1 (signal transducer and activator of transcription-1) (<xref ref-type="bibr" rid="B60">60</xref>). In addition, glycine regulates miR-19a-3p/AMPK pathway to alleviate ischemic stroke injury (<xref ref-type="bibr" rid="B61">61</xref>). Therefore, glycine may promote M1 macrophage polarization by regulating miR-19a-3p (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). Besides influencing M1 macrophages polarization, miR-19a-3p is capable of suppressing M2 macrophage polarization by inhibiting STAT3 when overexpressed (<xref ref-type="bibr" rid="B62">62</xref>) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>).</p>
<p>Notably, miRNAs can regulate GlyTs function. Human GlyT1 possesses several miRNAs targeting sites within the 3&#x2019;UTR (miR-7, miR-30, miR-96, miR-137, miR-141). Among them, miR-96 and miR-137 negatively regulate GlyT1 under physiological conditions (<xref ref-type="bibr" rid="B63">63</xref>) (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2E</bold>
</xref>). It is intriguing to investigate whether microRNAs mediate the regulation of glycinergic system in macrophage polarization.</p>
</sec>
<sec id="s6">
<title>Application of Glycine in Macrophage-Related Diseases</title>
<sec id="s6_1">
<title>Obesity and Associated Metabolic Diseases</title>
<p>The white adipose tissue can produce many adipokines such as leptin, TNF-&#x3b1;, and interleukins, due to the accumulation of macrophages (<xref ref-type="bibr" rid="B64">64</xref>&#x2013;<xref ref-type="bibr" rid="B66">66</xref>). In adipocytes differentiated 3T3-L1 cells, applying 10 mM glycine in the medium decreases the expression of IL-6, resistin and TNF-&#x3b1; (<xref ref-type="bibr" rid="B67">67</xref>). Similarly, in glutamate-induced obese mice, the application of glycine reprograms fat metabolism and decreases the expression level of TNF-&#x3b1; and IL-6 (<xref ref-type="bibr" rid="B68">68</xref>). Serum and liver glycine levels in obese rats are lower than thin rats (<xref ref-type="bibr" rid="B69">69</xref>) and dietary supplementation with glycine lowers circulating triglycerides in Zucker fatty rats (<xref ref-type="bibr" rid="B70">70</xref>). These phenomena were also found in humans. The plasma glycine level is lower in obese and diabetic patients (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>) in comparison to healthy donor. In clinical application, dietary supplementation of glycine can improve insulin response and glucose tolerance (<xref ref-type="bibr" rid="B73">73</xref>, <xref ref-type="bibr" rid="B74">74</xref>). Impaired glycine metabolism may play a causative role in NAFLD, glycine-based treatment stimulating hepatic GSH synthesis in experimental NFLD (<xref ref-type="bibr" rid="B75">75</xref>). These results show that glycine could be helpful for alleviating inflammatory state in obesity.</p>
<p>Non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) are stubborn illnesses because of their prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies (<xref ref-type="bibr" rid="B76">76</xref>). Macrophages are involved in the development of steatosis, inflammation and fibrosis in NASH (<xref ref-type="bibr" rid="B77">77</xref>). Furthermore, an increase of M1 macrophages in adipose tissue contribute to NASH due to its secretion of various proinflammatory signals, and these inflammatory factors move to hepatic and trigger local macrophages polarization (<xref ref-type="bibr" rid="B78">78</xref>). It has been found that glycine alleviates NASH index in high fat and high sucrose induced NASH in rats (<xref ref-type="bibr" rid="B79">79</xref>). Like obesity patients, plasma glycine levels are lower in NAFLD patients (<xref ref-type="bibr" rid="B80">80</xref>). Moreover, in a metabolic steatohepatitis mice model, glycine decreases cytokines level and increases M2/M1 macrophages ratio (<xref ref-type="bibr" rid="B81">81</xref>). These results indicate that glycine may have potential to treat non-alcoholic hepatic diseases.</p>
<p>Glycine could regulate the intestinal flora and decrease intestine macrophage infiltration in mice under LPS stimulation (<xref ref-type="bibr" rid="B82">82</xref>). Interestingly, pro-inflammatory macrophage accumulation was found in obesity humans (<xref ref-type="bibr" rid="B83">83</xref>). Besides this, increased pro-inflammatory macrophages were found in the gut of high fat diet (HFD) fed mice (<xref ref-type="bibr" rid="B84">84</xref>). Thus, glycine may potential to decrease intestinal pro-inflammatory macrophages infiltration to help alleviating obesity and obesity associated metabolic diseases. Whether glycine can affect intestinal macrophage by affecting intestinal flora needs to be further investigation.</p>
</sec>
<sec id="s6_2">
<title>Ischemia-Reperfusion Injury</title>
<p>Ischemia-reperfusion injury is a serious problem after visceral transplantation (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>). Glycine significantly increases the survival rate after ischemia-reperfusion and alleviates the inflammatory injury from ischemia-reperfusion. Local perfusion with glycine can alleviate warm ischemia-reperfusion injury in small intestine of rats (<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>) and liver of mice (<xref ref-type="bibr" rid="B89">89</xref>&#x2013;<xref ref-type="bibr" rid="B91">91</xref>), as well as renal ischemia reperfusion injury caused by renal hypothermic (<xref ref-type="bibr" rid="B92">92</xref>). Interestingly, there exists a solid connection between ischemia-reperfusion injury and macrophages. The activation and migration of macrophages can aggravate inflammation, apoptosis or other stress in apparatus (<xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B94">94</xref>). Fortunately, the researchers found that glycine inhibited the activation of Kupffer cells and their interleukins production during liver ischemia-reperfusion (<xref ref-type="bibr" rid="B89">89</xref>, <xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B95">95</xref>). In short, glycine is helpful for postoperative recovery after ischemia-reperfusion.</p>
</sec>
<sec id="s6_3">
<title>Cancer/Tumor</title>
<p>Tumor associated macrophages (TAMs) are highly prevalent in many solid tumors (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B97">97</xref>). Disrupting the malignant interaction between TAMs and cancer cells may greatly contribute to the survival of cancer patient. However, current targeted therapies of TAMs still fail to give a satisfied effect in tumor control because it is truly difficult to completely clear tumor and simultaneously avoid the high toxicity to patients. Thus, it is urgent to find effective and safe targeted TAM therapies.</p>
<p>Regulating TAMs is one of the targets for cancer treatment. Because of its infinite proliferation ability, cancer cells are highly dependent on glycine and serine uptake for nucleotide synthesis and one-carbon metabolism. Silencing SHMT2 and/or depriving extracellular glycine halts the rapid proliferation of cancer cells, but is not capable of blocking their proliferation completely (<xref ref-type="bibr" rid="B97">97</xref>). This phenomenon can rescue by the addition of glycine in the medium (<xref ref-type="bibr" rid="B97">97</xref>). Strikingly, glycine is generally consumed by highly proliferative cancer cells, but released by slow-proliferating cells (<xref ref-type="bibr" rid="B97">97</xref>). Thus, the demands of glycine may be distinct in different types or different proliferation states of cancer cells. Furthermore, high glycine concentration in tumor microenvironment can be consider as a clinical indicator of poor prognosis of tumor (<xref ref-type="bibr" rid="B98">98</xref>). Regulating glycine level in the tumor microenvironment may be an effective treatment for inhibiting the proliferation of cancer cells.</p>
</sec>
<sec id="s6_4">
<title>Colitis</title>
<p>Colitis is an idiopathic intestinal inflammatory disease involving the colon, the clinical manifestations are diarrhea, abdominal pain, and even bloody stools (<xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>). Glycine altered colon microbiota and serum amino acids concentration, as well as colon interleukin level in 5% acetic acid induced colitis in mice (<xref ref-type="bibr" rid="B101">101</xref>). Similarly, dietary supplementation of 5% glycine alleviates colitis induced by 2,4,6-trinitrobenzene sulphonic acid (TNBS) and dextran sulfate sodium (DSS) in rats (<xref ref-type="bibr" rid="B102">102</xref>). Besides this, glycine supplementation ameliorates <italic>C. redentium</italic>- induced colitis and enhancing the abundance of <italic>Lactobacillus (</italic>
<xref ref-type="bibr" rid="B103">103</xref>). In summary, glycine supplementation may a nutritional strategy to alleviate colitis.</p>
<p>Taken together, these findings suggest that glycine has a certain preventive effect on macrophage-related diseases which are summarized in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>. However, the beneficial effects of glycine in other macrophage-associated diseases and the underlying mechanisms still need further investigation.</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Beneficial effects of glycine in other macrophage-associated diseases.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Model</th>
<th valign="top" align="center">Dose</th>
<th valign="top" align="center">Features</th>
<th valign="top" align="center">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">
<bold>Arthritis (Rat)</bold>
</td>
<td valign="top" align="left">Dietary supplementation with 5% glycine</td>
<td valign="top" align="left">Pro-inflammatory cytokines &#x2193;</td>
<td valign="top" align="center"> (<xref ref-type="bibr" rid="B104">104</xref>, <xref ref-type="bibr" rid="B105">105</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Acute pancreatitis (AP) (Rat)</bold>
</td>
<td valign="top" align="left">Intravenous injection of 100/300 mmol glycine</td>
<td valign="top" align="left">Pathological structure &#x2191;; Pro-inflammatory cytokines &#x2193;</td>
<td valign="top" align="center"> (<xref ref-type="bibr" rid="B106">106</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">MPO activity &#x2193;</td>
</tr>
<tr>
<td valign="top" rowspan="2" align="left">
<bold>Oral gingival inflammation (Cultured gingival epithelial cells)</bold>
</td>
<td valign="top" rowspan="2" align="left">5mM glycine supplemented in culture medium</td>
<td valign="top" align="left">Pro-inflammatory interleukin level &#x2193;</td>
<td valign="top" rowspan="2" align="center"> (<xref ref-type="bibr" rid="B107">107</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Nf-&#x3ba;B activation &#x2193;</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Endotoxin (LPS) shock (Rat)</bold>
</td>
<td valign="top" align="left">Dietary supplementation with 5% glycine</td>
<td valign="top" align="left">Survival rate &#x2191;,</td>
<td valign="top" rowspan="2" align="center"> (<xref ref-type="bibr" rid="B108">108</xref>)</td>
</tr>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="left">Serum pro-inflammatory cytokines level &#x2193;</td>
</tr>
<tr>
<td valign="top" align="left">
<bold>Colitis (Rat and mice)</bold>
</td>
<td valign="top" rowspan="2" align="left">Dietary supplementation with 5% glycine</td>
<td valign="top" rowspan="2" align="left">Macroscopic and histologic scores &#x2191;</td>
<td valign="top" rowspan="2" align="center"> (<xref ref-type="bibr" rid="B101">101</xref>, <xref ref-type="bibr" rid="B102">102</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>&#x2191;, increase/up-regulate; &#x2193;, decrease/down-regulate.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="s7">
<title>Concluding Remarks</title>
<p>In this review, we introduced glycinergic system in macrophages, and summarized how glycine shapes macrophages polarization. For glycinergic system, GlyRs could be found in macrophages, and the subunits of GlyRs are varied in macrophages with different origins. Though it has been already noted that NAATs exist in macrophages, it is not clear which type of NAATs is expressed in macrophages. Glycine is supposed to affect macrophage through different contributors. Mechanistically, glycine alters macrophage signaling pathways (e.g., NF-&#x3ba;B, NRF2, and Akt) and miRNAs. Interestingly, other signaling pathways [e.g., ERK (<xref ref-type="bibr" rid="B109">109</xref>)] might also mediate the functions of glycine. Therefore, it is not surprising that glycine could influence the progresses of several macrophage-associated diseases (e.g., colitis and NAFLD).</p>
<p>Indeed, the influences of glycine in macrophage activation are still worth further investigation. Firstly, it is not clear whether glycine can affect methylation reaction in macrophages. In one-carbon metabolism, glycine partly provides the carbon backbones required for the generation of SAM (<xref ref-type="bibr" rid="B110">110</xref>), which is the main methyl donor for cellular methylation reaction (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B111">111</xref>). Recent studies have shown that the methylation of histone (<xref ref-type="bibr" rid="B39">39</xref>), DNA (<xref ref-type="bibr" rid="B112">112</xref>) or mRNA (<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B114">114</xref>) is closely related to macrophage polarization. Therefore, glycine is likely to affect macrophage polarization through methylation modification. Secondly, there are few studies on the effect of glycine on the metabolism of macrophages. Macrophage metabolism is highly related with the function output of macrophages (<xref ref-type="bibr" rid="B54">54</xref>). Considering glycine could impact HIF-1&#x3b1; and mTORC1 that are related to cellular metabolism (e.g., glycolysis), thus studying the effect of glycine on macrophage metabolism is meaningful to reveal the working mechanism of glycine on macrophages function. Finally, studying the effect of glycine on macrophages in the tumor microenvironment may reveal a potential target for cancer therapy. Therefore, it is necessary to find out the relationship between glycine, macrophage function and cancer progression.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author Contributions</title>
<p>ZG wrote the review article. ZG, SH, and XW revised the review article. CH, JF, and LF helped with designing figures and finding relevant literatures. MZ and DX reviewed and revised the grammar error in the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by the Guangdong Basic and Applied Basic Research Foundation (2019B1515210002) and National Natural Science Foundation of China (31922079).</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dixon</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Barnes</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Pritchard</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Nagy</surname> <given-names>LE</given-names>
</name>
</person-group>. <article-title>Kupffer Cells in the Liver</article-title>. <source>Compr Physiol</source> (<year>2013</year>) <volume>3</volume>:<page-range>785&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cphy.c120026</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Boddeke</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Kettenmann</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Microglia in Physiology and Disease</article-title>. <source>Annu Rev Physiol</source> (<year>2017</year>) <volume>79</volume>:<page-range>619&#x2013;43</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034406</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Wynn</surname> <given-names>TA</given-names>
</name>
</person-group>. <article-title>Protective and Pathogenic Functions of Macrophage Subsets</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>:<page-range>723&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nri3073</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Epelman</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lavine</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Randolph</surname> <given-names>GJ</given-names>
</name>
</person-group>. <article-title>Origin and Functions of Tissue Macrophages</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>:<fpage>21</fpage>&#x2013;<lpage>35</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.013</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mills</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Ley</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>M1 and M2 Macrophages: The Chicken and the Egg of Immunity</article-title>. <source>J Innate Immun</source> (<year>2014</year>) <volume>6</volume>:<page-range>716&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000364945</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shapouri-Moghaddam</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mohammadian</surname> <given-names>S</given-names>
</name>
<name>
<surname>Vazini</surname> <given-names>H</given-names>
</name>
<name>
<surname>Taghadosi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Esmaeili</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Mardani</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Macrophage Plasticity, Polarization, and Function in Health and Disease</article-title>. <source>J Cell Physiol</source> (<year>2018</year>) <volume>233</volume>:<page-range>6425&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcp.26429</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Melatonin in Macrophage Biology: Current Understanding and Future Perspectives</article-title>. <source>J Pineal Res</source> (<year>2019</year>) <volume>66</volume>:<fpage>e12547</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jpi.12547</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Reid Bolus</surname> <given-names>W</given-names>
</name>
<name>
<surname>Hasty</surname> <given-names>AH</given-names>
</name>
</person-group>. <article-title>A Decade of Progress in Adipose Tissue Macrophage Biology</article-title>. <source>Immunol Rev</source> (<year>2014</year>) <volume>262</volume>:<page-range>134&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/imr.12216</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galv&#xe1;n-Pe&#xf1;a</surname> <given-names>S</given-names>
</name>
<name>
<surname>O&#x2019;Neill</surname> <given-names>LA</given-names>
</name>
</person-group>. <article-title>Metabolic Reprograming in Macrophage Polarization</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<elocation-id>420</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2014.00420</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thapa</surname> <given-names>B</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Metabolic Influence on Macrophage Polarization and Pathogenesis</article-title>. <source>BMB Rep</source> (<year>2019</year>) <volume>52</volume>:<page-range>360&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.5483/BMBRep.2019.52.6.140</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gogoi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Datey</surname> <given-names>A</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>KT</given-names>
</name>
<name>
<surname>Chakravortty</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Dual Role of Arginine Metabolism in Establishing Pathogenesis</article-title>. <source>Curr Opin Microbiol</source> (<year>2016</year>) <volume>29</volume>:<page-range>43&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mib.2015.10.005</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname> <given-names>NR</given-names>
</name>
<name>
<surname>Jahoor</surname> <given-names>F</given-names>
</name>
<name>
<surname>Ware</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jackson</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>Endogenous Glycine and Tyrosine Production is Maintained in Adults Consuming a Marginal-Protein Diet</article-title>. <source>Am J Clin Nutr</source> (<year>2002</year>) <volume>75</volume>:<page-range>511&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ajcn/75.3.511</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>SW</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Amino Acids and Immune Function</article-title>. <source>Br J Nutr</source> (<year>2007</year>) <volume>98</volume>:<page-range>237&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1017/S000711450769936X</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mel&#xe9;ndez-Hevia</surname> <given-names>E</given-names>
</name>
<name>
<surname>De Paz-Lugo</surname> <given-names>P</given-names>
</name>
<name>
<surname>Cornish-Bowden</surname> <given-names>A</given-names>
</name>
<name>
<surname>C&#xe1;rdenas</surname> <given-names>ML</given-names>
</name>
</person-group>. <article-title>A Weak Link in Metabolism: The Metabolic Capacity for Glycine Biosynthesis Does Not Satisfy the Need for Collagen Synthesis</article-title>. <source>J Biosci</source> (<year>2009</year>) <volume>34</volume>:<page-range>853&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12038-009-0100-9</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wheeler</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Froh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schemmer</surname> <given-names>P</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>L-Glycine: A Novel Antiinflammatory, Immunomodulatory, and Cytoprotective Agent</article-title>. <source>Curr Opin Clin Nutr Metab Care</source> (<year>2003</year>) <volume>6</volume>:<page-range>229&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00075197-200303000-00013</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheeler</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Ikejema</surname> <given-names>K</given-names>
</name>
<name>
<surname>Enomoto</surname> <given-names>N</given-names>
</name>
<name>
<surname>Stacklewitz</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Seabra</surname> <given-names>V</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine: A New Anti-Inflammatory Immunonutrient</article-title>. <source>Cell Mol Life Sci</source> (<year>1999</year>) <volume>56</volume>:<page-range>843&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s000180050030</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aprison</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Werman</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The Distribution of Glycine in Cat Spinal Cord and Roots</article-title>. <source>Life Sci</source> (<year>1965</year>) <volume>4</volume>:<page-range>2075&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0024-3205(65)90325-5</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Perlmutter</surname> <given-names>SI</given-names>
</name>
</person-group>. <article-title>Sensitivity of Spinal Neurons to GABA and Glycine During Voluntary Movement in Behaving Monkeys</article-title>. <source>J Neurophysiol</source> (<year>2013</year>) <volume>109</volume>:<fpage>193</fpage>&#x2013;<lpage>201</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/jn.01081.2011</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curtis</surname> <given-names>DR</given-names>
</name>
<name>
<surname>H&#xf6;sli</surname> <given-names>L</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>Inhibition of Spinal Neurons by Glycine</article-title>. <source>Nature</source> (<year>1967</year>) <volume>215</volume>:<page-range>1502&#x2013;3</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/2151502a0</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Betz</surname> <given-names>H</given-names>
</name>
<name>
<surname>Laube</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Glycine Receptors: Recent Insights Into Their Structural Organization and Functional Diversity</article-title>. <source>J Neurochem</source> (<year>2006</year>) <volume>97</volume>:<page-range>1600&#x2013;10</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.03908.x</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeiffer</surname> <given-names>F</given-names>
</name>
<name>
<surname>Graham</surname> <given-names>D</given-names>
</name>
<name>
<surname>Betz</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Purification by Affinity Chromatography of the Glycine Receptor of Rat Spinal Cord</article-title>. <source>J Biol Chem</source> (<year>1982</year>) <volume>257</volume>:<page-range>9389&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0021-9258(18)34082-1</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Froh</surname> <given-names>M</given-names>
</name>
<name>
<surname>Thurman</surname> <given-names>RG</given-names>
</name>
<name>
<surname>Wheeler</surname> <given-names>MD</given-names>
</name>
</person-group>. <article-title>Molecular Evidence for a Glycine-Gated Chloride Channel in Macrophages and Leukocytes</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source> (<year>2002</year>) <volume>283</volume>:<page-range>G856&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.00503.2001</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carmans</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hendriks</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Thewissen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Van den Eynden</surname> <given-names>J</given-names>
</name>
<name>
<surname>Stinissen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rigo</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>The Inhibitory Neurotransmitter Glycine Modulates Macrophage Activity by Activation of Neutral Amino Acid Transporters</article-title>. <source>J Neurosci Res</source> (<year>2010</year>) <volume>88</volume>:<page-range>2420&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jnr.22395</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Du</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>The Origins and Homeostasis of Monocytes and Tissue-Resident Macrophages in Physiological Situation</article-title>. <source>J Cell Physiol</source> (<year>2018</year>) <volume>233</volume>:<page-range>6425&#x2013;39</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jcp.26461</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikejima</surname> <given-names>K</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Stachlewitz</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Thurman</surname> <given-names>RG</given-names>
</name>
</person-group>. <article-title>Kupffer Cells Contain a Glycine-Gated Chloride Channel</article-title>. <source>Am J Physiol</source> (<year>1997</year>) <volume>272</volume>:<page-range>G1581&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.1997.272.6.G1581</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Legendre</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>The Glycinergic Inhibitory Synapse</article-title>. <source>Cell Mol Life Sci</source> (<year>2001</year>) <volume>58</volume>:<page-range>760&#x2013;93</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/PL00000899</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wheeler</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Thurman</surname> <given-names>RG</given-names>
</name>
</person-group>. <article-title>Production of Superoxide and TNF-Alpha From Alveolar Macrophages is Blunted by Glycine</article-title>. <source>Am J Physiol</source> (<year>1999</year>) <volume>277</volume>:<page-range>L952&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1152/ajplung.1999.277.5.L952</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eder</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Ion Channels in Microglia (Brain Macrophages)</article-title>. <source>Am J Physiol</source> (<year>1998</year>) <volume>275</volume>:<page-range>C327&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.1998.275.2.C327</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyde</surname> <given-names>R</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>PM</given-names>
</name>
<name>
<surname>Hundal</surname> <given-names>HS</given-names>
</name>
</person-group>. <article-title>Amino Acid Transporters: Roles in Amino Acid Sensing and Signalling in Animal Cells</article-title>. <source>Biochem J</source> (<year>2003</year>) <volume>373</volume>:<fpage>1</fpage>&#x2013;<lpage>18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bj20030405</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>W</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Solute Carrier Transporters: The Metabolic Gatekeepers of Immune Cells</article-title>. <source>Acta Pharm Sin B</source> (<year>2020</year>) <volume>10</volume>:<fpage>61</fpage>&#x2013;<lpage>78</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.apsb.2019.12.006</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schilling</surname> <given-names>T</given-names>
</name>
<name>
<surname>Eder</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>A Novel Physiological Mechanism of Glycine-Induced Immunomodulation: Na+-Coupled Amino Acid Transporter Currents in Cultured Brain Macrophages</article-title>. <source>J Physiol</source> (<year>2004</year>) <volume>559</volume>:<fpage>35</fpage>&#x2013;<lpage>40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/jphysiol.2004.070763</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Glycine Metabolism in Animals and Humans: Implications for Nutrition and Health</article-title>. <source>Amino Acids</source> (<year>2013</year>) <volume>45</volume>:<page-range>463&#x2013;77</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00726-013-1493-1</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amelio</surname> <given-names>I</given-names>
</name>
<name>
<surname>Cutruzzola</surname> <given-names>F</given-names>
</name>
<name>
<surname>Antonov</surname> <given-names>A</given-names>
</name>
<name>
<surname>Agostini</surname> <given-names>M</given-names>
</name>
<name>
<surname>Melino</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Serine and Glycine Metabolism in Cancer</article-title>. <source>Trends Biochem Sci</source> (<year>2014</year>) <volume>39</volume>:<page-range>191&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tibs.2014.02.004</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnstein</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Neuberger</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>The Synthesis of Glycine and Serine by the Rat</article-title>. <source>Biochem J</source> (<year>1953</year>) <volume>55</volume>:<page-range>271&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/bj0550271</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Locasale</surname> <given-names>JW</given-names>
</name>
</person-group>. <article-title>Serine, Glycine and One-Carbon Units: Cancer Metabolism in Full Circle</article-title>. <source>Nat Rev Cancer</source> (<year>2013</year>) <volume>13</volume>:<page-range>572&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrc3557</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ducker</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Ghergurovich</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Mainolfi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Suri</surname> <given-names>V</given-names>
</name>
<name>
<surname>Jeong</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Hsin-Jung Li</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Human SHMT Inhibitors Reveal Defective Glycine Import as a Targetable Metabolic Vulnerability of Diffuse Large B-Cell Lymphoma</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2017</year>) <volume>114</volume>:<page-range>11404&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1706617114</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Y</given-names>
</name>
<name>
<surname>He</surname> <given-names>F</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xin</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Serine Supports IL-1beta Production in Macrophages Through mTOR Signaling</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>1866</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01866</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodriguez</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Ducker</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Billingham</surname> <given-names>LK</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Mainolfi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Suri</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Serine Metabolism Supports Macrophage IL-1beta Production</article-title>. <source>Cell Metab</source> (<year>2019</year>) <volume>29</volume>:<fpage>1003</fpage>&#x2013;<lpage>11.e4</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2019.01.014</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Chi</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>One-Carbon Metabolism Supports S-Adenosylmethionine and Histone Methylation to Drive Inflammatory Macrophages</article-title>. <source>Mol Cell</source> (<year>2019</year>) <volume>75</volume>:<fpage>1147</fpage>&#x2013;<lpage>60.e5</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.molcel.2019.06.039</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacobs</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Harrison</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>Structure of an IkappaBalpha/NF-kappaB Complex</article-title>. <source>Cell</source> (<year>1998</year>) <volume>95</volume>:<page-range>749&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81698-0</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solt</surname> <given-names>LA</given-names>
</name>
<name>
<surname>May</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>The IkappaB Kinase Complex: Master Regulator of NF-kappaB Signaling</article-title>. <source>Immunol Res</source> (<year>2008</year>) <volume>42</volume>:<fpage>3</fpage>&#x2013;<lpage>18</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12026-008-8025-1</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivashkiv</surname> <given-names>LB</given-names>
</name>
</person-group>. <article-title>Ifn&#x3b3;: Signalling, Epigenetics and Roles in Immunity, Metabolism, Disease and Cancer Immunotherapy</article-title>. <source>Nat Rev Immunol</source> (<year>2018</year>) <volume>18</volume>:<page-range>545&#x2013;58</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41577-018-0029-z</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname> <given-names>PJ</given-names>
</name>
</person-group>. <article-title>Macrophage Polarization</article-title>. <source>Annu Rev Physiol</source> (<year>2017</year>) <volume>79</volume>:<page-range>541&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034339</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorrington</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Fraser</surname> <given-names>IDC</given-names>
</name>
</person-group>. <article-title>NF-&#x3ba;b Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>705</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2019.00705</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blancas-Flores</surname> <given-names>G</given-names>
</name>
<name>
<surname>Alarc&#xf3;n-Aguilar</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Garc&#xed;a-Macedo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Almanza-P&#xe9;rez</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Flores-S&#xe1;enz</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Rom&#xe1;n-Ramos</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Suppresses TNF-&#x3b1;-Induced Activation of NF-&#x3ba;b in Differentiated 3T3-L1 Adipocytes</article-title>. <source>Eur J Pharmacol</source> (<year>2012</year>) <volume>689</volume>:<page-range>270&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2012.06.025</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Contreras-Nu&#xf1;ez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Blancas-Flores</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>M</given-names>
</name>
<name>
<surname>Almanza-Perez</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Gomez-Zamudio</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Ventura-Gallegosc</surname> <given-names>JL</given-names>
</name>
<etal/>
</person-group>. <article-title>Participation of the IKK-&#x3b1;/&#x3b2; Complex in the Inhibition of the TNF-&#x3b1;/NF-&#x3ba;b Pathway by Glycine: Possible Involvement of a Membrane Receptor Specific to Adipocytes</article-title>. <source>Biomed Pharmacother</source> (<year>2018</year>) <volume>102</volume>:<page-range>120&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2018.03.048</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Regulating NLRP3 Inflammasome and NRF2 Signaling</article-title>. <source>Nutrients</source> (<year>2020</year>) <volume>12</volume>(<issue>3</issue>):<fpage>611</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu12030611</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>PI3K/AKT Pathway as a Key Link Modulates the Multidrug Resistance of Cancers</article-title>. <source>Cell Death Dis</source> (<year>2020</year>) <volume>11</volume>:<fpage>797</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41419-020-02998-6</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haque</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Jantan</surname> <given-names>I</given-names>
</name>
<name>
<surname>Harikrishnan</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Zerumbone Suppresses the Activation of Inflammatory Mediators in LPS-Stimulated U937 Macrophages Through MyD88-Dependent NF-&#x3ba;b/MAPK/PI3K-Akt Signaling Pathways</article-title>. <source>Int Immunopharmacol</source> (<year>2018</year>) <volume>55</volume>:<page-range>312&#x2013;22</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2018.01.001</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>XY</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>MX</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>SF</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Exhibits Neuroprotective Effects in Ischemic Stroke in Rats Through the Inhibition of M1 Microglial Polarization <italic>via</italic> the NF-&#x3ba;b P65/Hif-1&#x3b1; Signaling Pathway</article-title>. <source>J Immunol</source> (<year>2019</year>) <volume>202</volume>:<page-range>1704&#x2013;14</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1801166</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>D</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Zhuang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Confers Neuroprotection Through PTEN/AKT Signal Pathway in Experimental Intracerebral Hemorrhage</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2018</year>) <volume>501</volume>:<fpage>85</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2018.04.171</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>SHMT2 Promotes Liver Regeneration Through Glycine-Activated Akt/mTOR Pathway</article-title>. <source>Transplantation</source> (<year>2019</year>) <volume>103</volume>:<page-range>e188&#x2013;97</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/TP.0000000000002747</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arranz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Doxaki</surname> <given-names>C</given-names>
</name>
<name>
<surname>Vergadi</surname> <given-names>E</given-names>
</name>
<name>
<surname>Martinez de la Torre</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Vaporidi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lagoudaki</surname> <given-names>ED</given-names>
</name>
<etal/>
</person-group>. <article-title>Akt1 and Akt2 Protein Kinases Differentially Contribute to Macrophage Polarization</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2012</year>) <volume>109</volume>:<page-range>9517&#x2013;22</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1119038109</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Ironing Out the Details: How Iron Orchestrates Macrophage Polarization</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.669566</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Essandoh</surname> <given-names>K</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>GC</given-names>
</name>
</person-group>. <article-title>MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response</article-title>. <source>Shock</source> (<year>2016</year>) <volume>46</volume>:<page-range>122&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/SHK.0000000000000604</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname> <given-names>X</given-names>
</name>
<name>
<surname>Akter</surname> <given-names>F</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>MicroRNA-26b/PTEN Signaling Pathway Mediates Glycine-Induced Neuroprotection in SAH Injury</article-title>. <source>Neurochem Res</source> (<year>2019</year>) <volume>44</volume>:<page-range>2658&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11064-019-02886-2</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization <italic>via</italic> PTEN/Pi3k&#x3b3; to Promote Pancreatic Cancer Metastasis</article-title>. <source>Cancer Res</source> (<year>2018</year>) <volume>78</volume>:<page-range>4586&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-3841</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname> <given-names>G</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>miR-301a Plays a Pivotal Role in Hypoxia-Induced Gemcitabine Resistance in Pancreatic Cancer</article-title>. <source>Exp Cell Res</source> (<year>2018</year>) <volume>369</volume>:<page-range>120&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yexcr.2018.05.013</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhuang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>ZF</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>P</given-names>
</name>
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Confers Neuroprotection Through microRNA-301a/PTEN Signaling</article-title>. <source>Mol Brain</source> (<year>2016</year>) <volume>9</volume>:<fpage>59</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13041-016-0241-3</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>MiR-19a-3p Suppresses M1 Macrophage Polarization by Inhibiting STAT1/IRF1 Pathway</article-title>. <source>Front Pharmacol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>614044</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2021.614044</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>ZJ</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>XS</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>TP</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>HX</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Glycine Improves Ischemic Stroke Through miR-19a-3p/AMPK/GSK-3&#x3b2;/HO-1 Pathway</article-title>. <source>Drug Des Devel Ther</source> (<year>2020</year>) <volume>14</volume>:<page-range>2021&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/DDDT.S248104</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Si</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Chuang</surname> <given-names>TH</given-names>
</name>
<etal/>
</person-group>. <article-title>MicroRNA-19a-3p Inhibits Breast Cancer Progression and Metastasis by Inducing Macrophage Polarization Through Downregulated Expression of Fra-1 Proto-Oncogene</article-title>. <source>Oncogene</source> (<year>2014</year>) <volume>33</volume>:<page-range>3014&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/onc.2013.258</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jim&#xe9;nez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Piniella</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gim&#xe9;nez</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zafra</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>Regulation of the Glycine Transporter GLYT1 by microRNAs</article-title>. <source>Neurochem Res</source> (<year>2021</year>). doi: <pub-id pub-id-type="doi">10.1007/s11064-021-03228-x</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Recasens</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ricart</surname> <given-names>W</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Real</surname> <given-names>JM</given-names>
</name>
</person-group>. <article-title>[Obesity and Inflammation]</article-title>. <source>Rev Med Univ Navarra</source> (<year>2004</year>) <volume>48</volume>:<fpage>49</fpage>&#x2013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1155/2007/95974</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanda</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tateya</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tamori</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kotani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hiasa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kitazawa</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>MCP-1 Contributes to Macrophage Infiltration Into Adipose Tissue, Insulin Resistance, and Hepatic Steatosis in Obesity</article-title>. <source>J Clin Invest</source> (<year>2006</year>) <volume>116</volume>:<page-range>1494&#x2013;505</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI26498</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>W</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bazer</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Glutamine Metabolism in Macrophages: A Novel Target for Obesity/Type 2 Diabetes</article-title>. <source>Adv Nutr</source> (<year>2019</year>) <volume>10</volume>:<page-range>321&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/advances/nmy084</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Macedo</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sanchez-Mu&#xf1;oz</surname> <given-names>F</given-names>
</name>
<name>
<surname>Almanza-Perez</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Duran-Reyes</surname> <given-names>G</given-names>
</name>
<name>
<surname>Alarcon-Aguilar</surname> <given-names>F</given-names>
</name>
<name>
<surname>Cruz</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Glycine Increases mRNA Adiponectin and Diminishes Pro-Inflammatory Adipokines Expression in 3T3-L1 Cells</article-title>. <source>Eur J Pharmacol</source> (<year>2008</year>) <volume>587</volume>:<page-range>317&#x2013;21</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejphar.2008.03.051</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almanza-Perez</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Alarcon-Aguilar</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Blancas-Flores</surname> <given-names>G</given-names>
</name>
<name>
<surname>Campos-Sepulveda</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Roman-Ramos</surname> <given-names>R</given-names>
</name>
<name>
<surname>Garcia-Macedo</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Regulates Inflammatory Markers Modifying the Energetic Balance Through PPAR and UCP-2</article-title>. <source>Biomed Pharmacother</source> (<year>2010</year>) <volume>64</volume>:<page-range>534&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2009.04.047</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simmons</surname> <given-names>RM</given-names>
</name>
<name>
<surname>McKnight</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Edwards</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Satterfield</surname> <given-names>MC</given-names>
</name>
</person-group>. <article-title>Obesity Increases Hepatic Glycine Dehydrogenase and Aminomethyltransferase Expression While Dietary Glycine Supplementation Reduces White Adipose Tissue in Zucker Diabetic Fatty Rats</article-title>. <source>Amino Acids</source> (<year>2020</year>) <volume>52</volume>(<issue>10</issue>):<page-range>1413&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00726-020-02901-9</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>White</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Lapworth</surname> <given-names>AL</given-names>
</name>
<name>
<surname>McGarrah</surname> <given-names>RW</given-names>
</name>
<name>
<surname>Kwee</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Crown</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Ilkayeva</surname> <given-names>O</given-names>
</name>
<etal/>
</person-group>. <article-title>Muscle-Liver Trafficking of BCAA-Derived Nitrogen Underlies Obesity-Related Glycine Depletion</article-title>. <source>Cell Rep</source> (<year>2020</year>) <volume>33</volume>:<fpage>108375</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.celrep.2020.108375</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okekunle</surname> <given-names>AP</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Du</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Abnormal Circulating Amino Acid Profiles in Multiple Metabolic Disorders</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2017</year>) <volume>132</volume>:<fpage>45</fpage>&#x2013;<lpage>58</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.diabres.2017.07.023</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adeva-Andany</surname> <given-names>M</given-names>
</name>
<name>
<surname>Souto-Adeva</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ameneiros-Rodr&#xed;guez</surname> <given-names>E</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez-Fern&#xe1;ndez</surname> <given-names>C</given-names>
</name>
<name>
<surname>Donapetry-Garc&#xed;a</surname> <given-names>C</given-names>
</name>
<name>
<surname>Dom&#xed;nguez-Montero</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Insulin Resistance and Glycine Metabolism in Humans</article-title>. <source>Amino Acids</source> (<year>2018</year>) <volume>50</volume>:<fpage>11</fpage>&#x2013;<lpage>27</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00726-017-2508-0</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gannon</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Nuttall</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Nuttall</surname> <given-names>FQ</given-names>
</name>
</person-group>. <article-title>The Metabolic Response to Ingested Glycine</article-title>. <source>Am J Clin Nutr</source> (<year>2002</year>) <volume>76</volume>:<page-range>1302&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ajcn/76.6.1302</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bassot</surname> <given-names>A</given-names>
</name>
<name>
<surname>Bulteau</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Pirola</surname> <given-names>L</given-names>
</name>
<name>
<surname>Morio</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases</article-title>. <source>Nutrients</source> (<year>2019</year>) <volume>11</volume>(<issue>6</issue>):<fpage>1356</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu11061356</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rom</surname> <given-names>O</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ghrayeb</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine-Based Treatment Ameliorates NAFLD by Modulating Fatty Acid Oxidation, Glutathione Synthesis, and the Gut Microbiome</article-title>. <source>Sci Transl Med</source> (<year>2020</year>) <volume>12</volume>(<issue>572</issue>):<fpage>eaaz2841</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.aaz2841</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neuschwander-Tetri</surname> <given-names>BA</given-names>
</name>
</person-group>. <article-title>Non-Alcoholic Fatty Liver Disease</article-title>. <source>BMC Med</source> (<year>2017</year>) <volume>15</volume>:<fpage>45</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12916-017-0806-8</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kazankov</surname> <given-names>K</given-names>
</name>
<name>
<surname>J&#xf8;rgensen</surname> <given-names>SMD</given-names>
</name>
<name>
<surname>Thomsen</surname> <given-names>KL</given-names>
</name>
<name>
<surname>M&#xf8;ller</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Vilstrup</surname> <given-names>H</given-names>
</name>
<name>
<surname>George</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>The Role of Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis</article-title>. <source>Nat Rev Gastroenterol Hepatol</source> (<year>2019</year>) <volume>16</volume>:<page-range>145&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41575-018-0082-x</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alisi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Carpino</surname> <given-names>G</given-names>
</name>
<name>
<surname>Oliveira</surname> <given-names>FL</given-names>
</name>
<name>
<surname>Panera</surname> <given-names>N</given-names>
</name>
<name>
<surname>Nobili</surname> <given-names>V</given-names>
</name>
<name>
<surname>Gaudio</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications</article-title>. <source>Mediators Inflamm</source> (<year>2017</year>) <volume>2017</volume>:<fpage>8162421</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/8162421</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Han</surname> <given-names>D</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Protects Against High Sucrose and High Fat-Induced non-Alcoholic Steatohepatitis in Rats</article-title>. <source>Oncotarget</source> (<year>2016</year>) <volume>7</volume>:<page-range>80223&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.18632/oncotarget.12831</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takashima</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ikejima</surname> <given-names>K</given-names>
</name>
<name>
<surname>Arai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yokokawa</surname> <given-names>J</given-names>
</name>
<name>
<surname>Kon</surname> <given-names>K</given-names>
</name>
<name>
<surname>Yamashina</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Prevents Metabolic Steatohepatitis in Diabetic KK-Ay Mice Through Modulation of Hepatic Innate Immunity</article-title>. <source>Am J Physiol Gastrointest Liver Physiol</source> (<year>2016</year>) <volume>311</volume>:<page-range>G1105&#x2013;13</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.00465.2015</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mu</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Protective Effects of Glycine Against Lipopolysaccharide-Induced Intestinal Apoptosis and Inflammation</article-title>. <source>Amino Acids</source> (<year>2021</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00726-021-03011-w</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rohm</surname> <given-names>TV</given-names>
</name>
<name>
<surname>Fuchs</surname> <given-names>R</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>RL</given-names>
</name>
<name>
<surname>Keller</surname> <given-names>L</given-names>
</name>
<name>
<surname>Baumann</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Bosch</surname> <given-names>AJT</given-names>
</name>
<etal/>
</person-group>. <article-title>Obesity in Humans Is Characterized by Gut Inflammation as Shown by Pro-Inflammatory Intestinal Macrophage Accumulation</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>.</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rohm</surname> <given-names>TV</given-names>
</name>
<name>
<surname>Alasfoor</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bosch</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Cavelti-Weder</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Targeting Intestinal Macrophages as a Potential Therapeutic Option in Obesity</article-title>. <source>Diabetes</source> (<year>2018</year>) <volume>67</volume>:<page-range>283&#x2013;OR</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db18-283-OR</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kahn</surname> <given-names>J</given-names>
</name>
<name>
<surname>Schemmer</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>Control of Ischemia-Reperfusion Injury in Liver Transplantation: Potentials for Increasing the Donor Pool</article-title>. <source>Visc Med</source> (<year>2018</year>) <volume>34</volume>:<page-range>444&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000493889</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehrabi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Mood Zh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sadeghi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Schmied</surname> <given-names>BM</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Welsch</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Thymoglobulin and Ischemia Reperfusion Injury in Kidney and Liver Transplantation</article-title>. <source>Nephrol Dial Transplant</source> (<year>2007</year>) <volume>22</volume>(<supplement>Suppl 8</supplement>):<fpage>viii54</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/ndt/gfm651</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>MA</given-names>
</name>
<name>
<surname>McCauley</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Influence of Glycine on Intestinal Ischemia-Reperfusion Injury</article-title>. <source>JPEN J Parenter Enteral Nutr</source> (<year>2002</year>) <volume>26</volume>:<page-range>130&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0148607102026002130</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>MA</given-names>
</name>
<name>
<surname>McCauley</surname> <given-names>RD</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>SE</given-names>
</name>
<name>
<surname>Hall</surname> <given-names>JC</given-names>
</name>
</person-group>. <article-title>Pretreatment With Glycine Reduces the Severity of Warm Intestinal Ischemic-Reperfusion Injury in the Rat</article-title>. <source>Ann Plast Surg</source> (<year>2001</year>) <volume>46</volume>:<page-range>320&#x2013;6</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/00000637-200103000-00020</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habib</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Hodgson</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Davidson</surname> <given-names>BR</given-names>
</name>
</person-group>. <article-title>The Role of Glycine in Hepatic Ischemia-Reperfusion Injury</article-title>. <source>Curr Pharm Des</source> (<year>2006</year>) <volume>12</volume>:<page-range>2953&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/138161206777947605</pub-id>
</citation>
</ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamanouchi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Eguchi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kamohara</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yanaga</surname> <given-names>K</given-names>
</name>
<name>
<surname>Okudaira</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tajima</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Reduces Hepatic Warm Ischaemia-Reperfusion Injury by Suppressing Inflammatory Reactions in Rats</article-title>. <source>Liver Int</source> (<year>2007</year>) <volume>27</volume>:<page-range>1249&#x2013;54</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1478-3231.2007.01564.x</pub-id>
</citation>
</ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ito</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ozasa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Noda</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Koike</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Arii</surname> <given-names>S</given-names>
</name>
<name>
<surname>Horikawa</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Effect of non-Essential Amino Acid Glycine Administration on the Liver Regeneration of Partially Hepatectomized Rats With Hepatic Ischemia/Reperfusion Injury</article-title>. <source>Clin Nutr</source> (<year>2008</year>) <volume>27</volume>:<page-range>773&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clnu.2008.06.012</pub-id>
</citation>
</ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mangino</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Murphy</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Grabau</surname> <given-names>GG</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>CB</given-names>
</name>
</person-group>. <article-title>Protective Effects of Glycine During Hypothermic Renal Ischemia-Reperfusion Injury</article-title>. <source>Am J Physiol</source> (<year>1991</year>) <volume>261</volume>:<page-range>F841&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajprenal.1991.261.5.F841</pub-id>
</citation>
</ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dirsch</surname> <given-names>O</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dahmen</surname> <given-names>U</given-names>
</name>
</person-group>. <article-title>Early Release of Macrophage Migration Inhibitory Factor After Liver Ischemia and Reperfusion Injury in Rats</article-title>. <source>Cytokine</source> (<year>2012</year>) <volume>57</volume>:<page-range>150&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cyto.2011.11.009</pub-id>
</citation>
</ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gazoni</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Tribble</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>MQ</given-names>
</name>
<name>
<surname>Unger</surname> <given-names>EB</given-names>
</name>
<name>
<surname>Farrar</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Ellman</surname> <given-names>PI</given-names>
</name>
<etal/>
</person-group>. <article-title>Pulmonary Macrophage Inhibition and Inhaled Nitric Oxide Attenuate Lung Ischemia-Reperfusion Injury</article-title>. <source>Ann Thorac Surg</source> (<year>2007</year>) <volume>84</volume>:<page-range>247&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.athoracsur.2007.02.036</pub-id>
</citation>
</ref>
<ref id="B94">
<label>94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Saeedi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>R</given-names>
</name>
<name>
<surname>Schultze</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Nickkholgh</surname> <given-names>A</given-names>
</name>
<name>
<surname>Herr</surname> <given-names>I</given-names>
</name>
<name>
<surname>Zorn</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Protects Partial Liver Grafts From Kupffer Cell-Dependent Ischemia-Reperfusion Injury Without Negative Effect on Regeneration</article-title>. <source>Amino Acids</source> (<year>2019</year>) <volume>51</volume>:<page-range>903&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00726-019-02722-5</pub-id>
</citation>
</ref>
<ref id="B95">
<label>95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>R&#xe4;ih&#xe4;</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Puolakkainen</surname> <given-names>PA</given-names>
</name>
</person-group>. <article-title>Tumor-Associated Macrophages (TAMs) as Biomarkers for Gastric Cancer: A Review</article-title>. <source>Chronic Dis Transl Med</source> (<year>2018</year>) <volume>4</volume>:<page-range>156&#x2013;63</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cdtm.2018.07.001</pub-id>
</citation>
</ref>
<ref id="B96">
<label>96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gambardella</surname> <given-names>V</given-names>
</name>
<name>
<surname>Castillo</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tarazona</surname> <given-names>N</given-names>
</name>
<name>
<surname>Gimeno-Valiente</surname> <given-names>F</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Ciarpaglini</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cabeza-Segura</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>The Role of Tumor-Associated Macrophages in Gastric Cancer Development and Their Potential as a Therapeutic Target</article-title>. <source>Cancer Treat Rev</source> (<year>2020</year>) <volume>86</volume>:<fpage>102015</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ctrv.2020.102015</pub-id>
</citation>
</ref>
<ref id="B97">
<label>97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname> <given-names>M</given-names>
</name>
<name>
<surname>Nilsson</surname> <given-names>R</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Madhusudhan</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kitami</surname> <given-names>T</given-names>
</name>
<name>
<surname>Souza</surname> <given-names>AL</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation</article-title>. <source>Science</source> (<year>2012</year>) <volume>336</volume>:<page-range>1040&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1218595</pub-id>
</citation>
</ref>
<ref id="B98">
<label>98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Redalen</surname> <given-names>KR</given-names>
</name>
<name>
<surname>Sitter</surname> <given-names>B</given-names>
</name>
<name>
<surname>Bathen</surname> <given-names>TF</given-names>
</name>
<name>
<surname>Gr&#xf8;holt</surname> <given-names>KK</given-names>
</name>
<name>
<surname>Hole</surname> <given-names>KH</given-names>
</name>
<name>
<surname>Dueland</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>High Tumor Glycine Concentration is an Adverse Prognostic Factor in Locally Advanced Rectal Cancer</article-title>. <source>Radiother Oncol</source> (<year>2016</year>) <volume>118</volume>:<page-range>393&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.radonc.2015.11.031</pub-id>
</citation>
</ref>
<ref id="B99">
<label>99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lazenby</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Giardiello</surname> <given-names>FM</given-names>
</name>
<name>
<surname>Bayless</surname> <given-names>TM</given-names>
</name>
<name>
<surname>Yardley</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Inflammatory Bowel Disease</article-title>. <source>N Engl J Med</source> (<year>1992</year>) <volume>326</volume>:<fpage>574</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJM199202203260815</pub-id>
</citation>
</ref>
<ref id="B100">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Regulation of Intestinal Epithelial Permeability by Tight Junctions</article-title>. <source>Cell Mol Life Sci</source> (<year>2013</year>) <volume>70</volume>:<page-range>631&#x2013;59</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-012-1070-x</pub-id>
</citation>
</ref>
<ref id="B101">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>The Effects of Dietary Glycine on the Acetic Acid-Induced Mouse Model of Colitis</article-title>. <source>Mediators Inflammation</source> (<year>2020</year>) <volume>2020</volume>:<fpage>5867627</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2020/5867627</pub-id>
</citation>
</ref>
<ref id="B102">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsune</surname> <given-names>I</given-names>
</name>
<name>
<surname>Ikejima</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hirose</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yoshikawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Enomoto</surname> <given-names>N</given-names>
</name>
<name>
<surname>Takei</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Dietary Glycine Prevents Chemical-Induced Experimental Colitis in the Rat</article-title>. <source>Gastroenterology</source> (<year>2003</year>) <volume>125</volume>:<page-range>775&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0016-5085(03)01067-9</pub-id>
</citation>
</ref>
<ref id="B103">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>IH</given-names>
</name>
<etal/>
</person-group>. <article-title>Glycine Attenuates Citrobacter Rodentium-Induced Colitis by Regulating ATF6-Mediated Endoplasmic Reticulum Stress in Mice</article-title>. <source>Mol Nutr Food Res</source> (<year>2021</year>) <volume>65</volume>:<fpage>e2001065</fpage>. doi: <pub-id pub-id-type="doi">10.1002/mnfr.202001065</pub-id>
</citation>
</ref>
<ref id="B104">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<name>
<surname>Bradford</surname> <given-names>BU</given-names>
</name>
<name>
<surname>Wheeler</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Stimpson</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Pink</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Brodie</surname> <given-names>TA</given-names>
</name>
<etal/>
</person-group>. <article-title>Dietary Glycine Prevents Peptidoglycan Polysaccharide-Induced Reactive Arthritis in the Rat: Role for Glycine-Gated Chloride Channel</article-title>. <source>Infect Immun</source> (<year>2001</year>) <volume>69</volume>:<page-range>5883&#x2013;91</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/IAI.69.9.5883-5891.2001</pub-id>
</citation>
</ref>
<ref id="B105">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vieira</surname> <given-names>CP</given-names>
</name>
<name>
<surname>De Oliveira</surname> <given-names>LP</given-names>
</name>
<name>
<surname>Da R&#xe9; Guerra</surname> <given-names>F</given-names>
</name>
<name>
<surname>Dos Santos De Almeida</surname> <given-names>M</given-names>
</name>
<name>
<surname>Marcondes</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Pimentel</surname> <given-names>ER</given-names>
</name>
</person-group>. <article-title>Glycine Improves Biochemical and Biomechanical Properties Following Inflammation of the Achilles Tendon</article-title>. <source>Anat Rec (Hoboken)</source> (<year>2015</year>) <volume>298</volume>:<page-range>538&#x2013;45</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/ar.23041</pub-id>
</citation>
</ref>
<ref id="B106">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ceyhan</surname> <given-names>GO</given-names>
</name>
<name>
<surname>Timm</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Bergmann</surname> <given-names>F</given-names>
</name>
<name>
<surname>G&#xfc;nther</surname> <given-names>A</given-names>
</name>
<name>
<surname>Aghdassi</surname> <given-names>AA</given-names>
</name>
<name>
<surname>Demir</surname> <given-names>IE</given-names>
</name>
<etal/>
</person-group>. <article-title>Prophylactic Glycine Administration Attenuates Pancreatic Damage and Inflammation in Experimental Acute Pancreatitis</article-title>. <source>Pancreatology</source> (<year>2011</year>) <volume>11</volume>:<fpage>57</fpage>&#x2013;<lpage>67</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000325972</pub-id>
</citation>
</ref>
<ref id="B107">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaumann</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kraus</surname> <given-names>D</given-names>
</name>
<name>
<surname>Winter</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wolf</surname> <given-names>M</given-names>
</name>
<name>
<surname>Deschner</surname> <given-names>J</given-names>
</name>
<name>
<surname>J&#xe4;ger</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Potential Immune Modularly Role of Glycine in Oral Gingival Inflammation</article-title>. <source>Clin Dev Immunol</source> (<year>2013</year>) <volume>2013</volume>:<fpage>808367</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2013/808367</pub-id>
</citation>
</ref>
<ref id="B108">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikejima</surname> <given-names>K</given-names>
</name>
<name>
<surname>Iimuro</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Forman</surname> <given-names>DT</given-names>
</name>
<name>
<surname>Thurman</surname> <given-names>RG</given-names>
</name>
</person-group>. <article-title>A Diet Containing Glycine Improves Survival in Endotoxin Shock in the Rat</article-title>. <source>Am J Physiol</source> (<year>1996</year>) <volume>271</volume>:<fpage>G97</fpage>&#x2013;<lpage>103</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpgi.1996.271.1.G97</pub-id>
</citation>
</ref>
<ref id="B109">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname> <given-names>W</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Melatonin Signaling in T Cells: Functions and Applications</article-title>. <source>J Pineal Res</source> (<year>2017</year>) <volume>62</volume>:<fpage>e12394</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jpi.12394</pub-id>
</citation>
</ref>
<ref id="B110">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ly</surname> <given-names>CH</given-names>
</name>
<name>
<surname>Lynch</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Ryall</surname> <given-names>JG</given-names>
</name>
</person-group>. <article-title>A Metabolic Roadmap for Somatic Stem Cell Fate</article-title>. <source>Cell Metab</source> (<year>2020</year>) <volume>31</volume>:<page-range>1052&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cmet.2020.04.022</pub-id>
</citation>
</ref>
<ref id="B111">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Maddocks</surname> <given-names>ODK</given-names>
</name>
</person-group>. <article-title>Serine and Functional Metabolites in Cancer</article-title>. <source>Trends Cell Biol</source> (<year>2017</year>) <volume>27</volume>:<page-range>645&#x2013;57</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tcb.2017.05.001</pub-id>
</citation>
</ref>
<ref id="B112">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>B</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Epigenetic Regulation of Macrophage Polarization and Inflammation by DNA Methylation in Obesity</article-title>. <source>JCI Insight</source> (<year>2016</year>) <volume>1</volume>:<fpage>e87748</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1172/jci.insight.87748</pub-id>
</citation>
</ref>
<ref id="B113">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>The N6-Methyladenosine (M6a)-Forming Enzyme METTL3 Facilitates M1 Macrophage Polarization Through the Methylation of STAT1 mRNA</article-title>. <source>Am J Physiol Cell Physiol</source> (<year>2019</year>) <volume>317</volume>:<page-range>C762&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.00212.2019</pub-id>
</citation>
</ref>
<ref id="B114">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>RNA M6a Methylation Orchestrates Cancer Growth and Metastasis <italic>via</italic> Macrophage Reprogramming</article-title>. <source>Nat Commun</source> (<year>2021</year>) <volume>12</volume>:<fpage>1394</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-021-21514-8</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>